Prognostic Value of p27, p53, and Vascular Endothelial Growth Factor in Dukes A and B Colon Cancer Patients Undergoing Potentially Curative Surgery

By Galizia Gennaro   Ferraraccio Francesca   Lieto Eva   Orditura Michele   Castellano Paolo   Imperatore Vincenzo   Romano Ciro   Vollaro Mario   Agostini Bruno   Pignatelli Carlo   Vita Ferdinando  

Diseases of the Colon & Rectum, Vol. 47, Iss. 11, 2004-11 ,pp. : 1904-1914

Springer Publishing Company

Access to resources Recommend Favorite

p21, p27, cyclin D, and p53 in rectal cancer: immunohistology with prognostic significance?

By Schwandner O.   Bruch H.-P.   Broll R.  

International Journal of Colorectal Disease, Vol. 17, Iss. 1, 2002-01 ,pp. : 11-19

Springer Publishing Company

Access to resources Recommend Favorite

Preclinical evaluation of a radiosensitizing effect of gemcitabine in p53 mutant and p53 wild type bladder cancer cells

By Fechner G.   Perabo F.G.E.   Schmidt D.H.   Haase L.   Ludwig E.   Schueller H.   Blatter J.   Mller S.C.   Albers P.  

Urology, Vol. 61, Iss. 2, 2003-02 ,pp. : 468-473

Elsevier

Access to resources Recommend Favorite

Synergistic Effects in Apoptosis Induction by Taurolidine and TRAIL in HCT-15 Colon Carcinoma Cells

By Chromik A. M.   Daigeler A.   Hilgert C.   Bulut D.   Geisler A.   Liu V.   Otte J. M.   Uhl W.   Mittelkötter U.  

Journal of Investigative Surgery, Vol. 20, Iss. 6, 2007-11 ,pp. : 339-348

Informa Healthcare

Access to resources Recommend Favorite

RAGE Activation by S100P in Colon Cancer Stimulates Growth, Migration, and Cell Signaling Pathways

By Fuentes Maren   Nigavekar Shraddha   Arumugam Thiruvengadam   Logsdon Craig   Schmidt Ann   Park Juliet   Huang Emina  

Diseases of the Colon & Rectum, Vol. 50, Iss. 8, 2007-08 ,pp. : 1230-1240

Springer Publishing Company

Access to resources Recommend Favorite